CPIX
Price
$4.35
Change
-$4.14 (-48.76%)
Updated
Oct 26 closing price
Capitalization
65.18M
7 days until earnings call
Intraday BUY SELL Signals
PRGO
Price
$15.82
Change
-$0.14 (-0.88%)
Updated
Oct 26 closing price
Capitalization
2.2B
8 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CPIX vs PRGO

CPIX vs PRGO Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CPIX vs. PRGO commentary
Oct 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPIX is a StrongBuy and PRGO is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CPIX with price predictions
Oct 26, 2026

CPIX in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 26, 2026

CPIX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 29 of 31 cases where CPIX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for CPIX's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

Following a +3.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where CPIX advanced for three days, in 179 of 216 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 38 of 44 cases where CPIX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 86%.

The Momentum Indicator moved below the 0 level on October 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CPIX as a result. In 100 of 111 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for CPIX turned negative on October 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 58 similar instances when the indicator turned negative. In 47 of the 58 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.

CPIX moved below its 50-day moving average on October 26, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CPIX crossed bearishly below the 50-day moving average on October 26, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CPIX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

The Aroon Indicator for CPIX entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. CPIX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 52 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.738) is normal, around the industry mean (8.413). P/E Ratio (-5.959) is within average values for comparable stocks, (-1.728). CPIX's Projected Growth (PEG Ratio) (17.640) is very high in comparison to the industry average of (2.152). CPIX's Dividend Yield (1.379) is considerably higher than the industry average of (0.047). P/S Ratio (2.362) is also within normal values, averaging (178.797).

The Tickeron Profit vs. Risk Rating rating for this company is 68 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CPIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock better than average.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for PRGO with price predictions
Oct 26, 2026

Momentum Indicator for PRGO turns positive, indicating new upward trend

PRGO saw its Momentum Indicator move above the 0 level on October 12, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In 59 of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at 68%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +4.26% 3-day Advance, the price is estimated to grow further. Considering data from situations where PRGO advanced for three days, in 179 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

The Aroon Indicator entered an Uptrend today. In 120 of 204 cases where PRGO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.

Bearish Trend Analysis

The 10-day RSI Indicator for PRGO moved out of overbought territory on October 19, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 23 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 74%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 59 cases where PRGO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 75%.

The Moving Average Convergence Divergence Histogram (MACD) for PRGO turned negative on October 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 33 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRGO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

PRGO broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 8 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.873) is normal, around the industry mean (8.413). P/E Ratio (-1.264) is within average values for comparable stocks, (-1.728). Projected Growth (PEG Ratio) (1.142) is also within normal values, averaging (2.152). Dividend Yield (0.073) settles around the average of (0.047) among similar stocks. P/S Ratio (0.454) is also within normal values, averaging (178.797).

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. PRGO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 89 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

FUNDAMENTALS RATINGS
CPIX vs PRGO: Fundamental Ratings
CPIX
PRGO
OUTLOOK RATING
1..100
1919
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
8
Undervalued
PROFIT vs RISK RATING
1..100
68100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
3437
P/E GROWTH RATING
1..100
1289
SEASONALITY SCORE
1..100
9021

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (8) in the Pharmaceuticals Other industry is somewhat better than the same rating for CPIX (52). This means that PRGO’s stock grew somewhat faster than CPIX’s over the last 12 months.

CPIX's Profit vs Risk Rating (68) in the Pharmaceuticals Other industry is in the same range as PRGO (100). This means that CPIX’s stock grew similarly to PRGO’s over the last 12 months.

CPIX's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as PRGO (98). This means that CPIX’s stock grew similarly to PRGO’s over the last 12 months.

CPIX's Price Growth Rating (34) in the Pharmaceuticals Other industry is in the same range as PRGO (37). This means that CPIX’s stock grew similarly to PRGO’s over the last 12 months.

CPIX's P/E Growth Rating (12) in the Pharmaceuticals Other industry is significantly better than the same rating for PRGO (89). This means that CPIX’s stock grew significantly faster than PRGO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CPIXPRGO
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
68%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
66%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
62%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 11 days ago
64%
Declines
ODDS (%)
Bearish Trend 8 days ago
81%
Bearish Trend 1 day ago
67%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
73%
Aroon
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
59%
COMPARISON
Comparison
Oct 27, 2026
Stock price -- (CPIX: $4.35 vs. PRGO: $15.82)
Brand notoriety: CPIX and PRGO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CPIX: 656% vs. PRGO: 56%
Market capitalization -- CPIX: $65.18M vs. PRGO: $2.2B
CPIX [@Pharmaceuticals: Generic] is valued at $65.18M. PRGO’s [@Pharmaceuticals: Generic] market capitalization is $2.2B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPIX’s FA Score shows that 1 FA rating(s) are green while PRGO’s FA Score has 1 green FA rating(s).

  • CPIX’s FA Score: 1 green, 4 red.
  • PRGO’s FA Score: 1 green, 4 red.
According to our system of comparison, CPIX is a better buy in the long-term than PRGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPIX’s TA Score shows that 3 TA indicator(s) are bullish while PRGO’s TA Score has 3 bullish TA indicator(s).

  • CPIX’s TA Score: 3 bullish, 7 bearish.
  • PRGO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, PRGO is a better buy in the short-term than CPIX.

Price Growth

CPIX (@Pharmaceuticals: Generic) experienced а -35.07% price change this week, while PRGO (@Pharmaceuticals: Generic) price change was -1.68% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.57%. For the same industry, the average monthly price growth was -11.91%, and the average quarterly price growth was +7.55%.

Reported Earning Dates

CPIX is expected to report earnings on Nov 03, 2026.

PRGO is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-3.57% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
CPIX
Daily Signal:
Gain/Loss:
PRGO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

CPIX and

Correlation & Price change

A.I.dvisor tells us that CPIX and ACB have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPIX and ACB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPIX
1D Price
Change %
CPIX100%
-48.76%
ACB - CPIX
27%
Poorly correlated
+0.52%
QNTM - CPIX
26%
Poorly correlated
-1.34%
GLAS - CPIX
23%
Poorly correlated
N/A
YCBD - CPIX
23%
Poorly correlated
+0.61%
PRGO - CPIX
22%
Poorly correlated
-0.88%
More

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with SUPN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then SUPN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
-0.88%
SUPN - PRGO
49%
Loosely correlated
+0.17%
ELAN - PRGO
37%
Loosely correlated
+1.95%
PBH - PRGO
35%
Loosely correlated
+0.73%
EVO - PRGO
35%
Loosely correlated
+1.33%
ALVO - PRGO
34%
Loosely correlated
+0.87%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TNUK20.560.19
+0.94%
Tortoise Nuclear Renaissance ETF
TDVG50.170.26
+0.53%
T. Rowe Price Dividend Growth ETF (TDVG)
ROPE30.340.07
+0.23%
Coastal Compass 100 ETF
GQI60.560.13
+0.22%
Natixis Gateway Quality Income ETF (GQI)
BPRO18.84-0.96
-4.84%
Bitwise Proficio Currency Debasement ETF (BPRO)